CoreScan* technology is designed to help physicians quickly and accurately quantify VAT during body composition analysis
As the numbers and cost of obesity climb globally, healthcare professionals continue to leverage advanced tools to help them monitor and manage obesity-related disease. Often, obesity is connected to excess levels of visceral adipose tissue (VAT), or visceral “belly” fat that surrounds abdominal organs – which in turn increases the risk of Type 2 Diabetes, hypertension, dyslipidemia and other aliments.
Unveiled earlier this year on GE’s iDXA system, CoreScan* technology is designed to help physicians quickly and accurately quantify VAT during body composition analysis. CoreScan helps give physicians and specialists, in a variety of clinical settings, immediate results that can help manage lifestyle interventions to benefit the patient.
At this year’s American Heart Association Scientific Sessions, researchers from Oregon Health & Science University and GE Healthcare presented data verifying that CoreScan measured by Dual-energy x-ray absorptiometry (DXA) is an effective way to precisely measure patients’ visceral fat. Furthermore, the data pointed to CoreScan as a fast, accurate, low x-ray-exposure method for helping healthcare professionals gauge cardiovascular risk factors.
Click on the video below to hear Dr. Mary Oates, a physical medicine and rehabilitation specialist in Santa Maria, CA, and Laura Stoltenberg, general manager of GE Healthcare’s body composition and bone densitometry business, discuss what visceral fat really is, and why it’s important to precisely quantify it during body composition exams.
* Trademark of General Electric Company